David Ross Parkinson - Net Worth and Insider Trading

David Ross Parkinson Net Worth

The estimated net worth of David Ross Parkinson is at least $117,558 dollars as of 2024-11-28. David Ross Parkinson is the CEO of ESSA Pharma Inc and owns about 65,675 shares of ESSA Pharma Inc (EPIX) stock worth over $117,558. Details can be seen in David Ross Parkinson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Ross Parkinson has not made any transactions after 2023-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David Ross Parkinson

To

David Ross Parkinson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Ross Parkinson owns 5 companies in total, including ESSA Pharma Inc (EPIX) , CTI BioPharma Corp (CTIC) , and Forte Biosciences Inc (FBRX) among others .

Click here to see the complete history of David Ross Parkinson’s form 4 insider trades.

Insider Ownership Summary of David Ross Parkinson

Ticker Comapny Transaction Date Type of Owner
EPIX ESSA Pharma Inc 2023-12-14 director & Chief Executive Officer
CTIC CTI BioPharma Corp 2018-05-17 director
FBRX Forte Biosciences Inc 2017-04-12 director
LIMIT LIMIT 2014-10-29 director
LIMIT LIMIT 2016-06-24 director

David Ross Parkinson Latest Holdings Summary

David Ross Parkinson currently owns a total of 1 stock. David Ross Parkinson owns 65,675 shares of ESSA Pharma Inc (EPIX) as of December 14, 2023, with a value of $117,558.

Latest Holdings of David Ross Parkinson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EPIX ESSA Pharma Inc 2023-12-14 65,675 1.79 117,558

Holding Weightings of David Ross Parkinson


David Ross Parkinson Form 4 Trading Tracker

According to the SEC Form 4 filings, David Ross Parkinson has made a total of 2 transactions in ESSA Pharma Inc (EPIX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ESSA Pharma Inc is the acquisition of 9,223 shares on December 14, 2023, which cost David Ross Parkinson around $21,213.

Insider Trading History of David Ross Parkinson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Ross Parkinson Trading Performance

GuruFocus tracks the stock performance after each of David Ross Parkinson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Ross Parkinson is 32.7%. GuruFocus also compares David Ross Parkinson's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Ross Parkinson within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Ross Parkinson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Ross Parkinson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 38.39 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 35.39 LIMIT LIMIT LIMIT LIMIT LIMIT

David Ross Parkinson Ownership Network

Ownership Network List of David Ross Parkinson

No Data

Ownership Network Relation of David Ross Parkinson

Insider Network Chart

David Ross Parkinson Owned Company Details

What does ESSA Pharma Inc do?

Who are the key executives at ESSA Pharma Inc?

David Ross Parkinson is the director & Chief Executive Officer of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include 10 percent owner Biotech Growth N V , Chief Operating Officer Peter Virsik , and Chief Financial Officer David S. Wood .

ESSA Pharma Inc (EPIX) Insider Trades Summary

Over the past 18 months, David Ross Parkinson made 1 insider transaction in ESSA Pharma Inc (EPIX) with a net purchase of 9,223. Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 81,945 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net sale of 7,879,583 shares made by Biotech Growth N V .

In summary, during the past 3 months, insiders sold 7,883,053 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 7,883,053 shares. During the past 18 months, 7,961,528 shares of ESSA Pharma Inc (EPIX) were sold and 108,953 shares were bought by its insiders, resulting in a net sale of 7,852,575 shares.

ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ESSA Pharma Inc Insider Transactions

No Available Data

David Ross Parkinson Mailing Address

Above is the net worth, insider trading, and ownership report for David Ross Parkinson. You might contact David Ross Parkinson via mailing address: C/o Threshold Pharmaceuticals, Inc., 170 Harbor Way Suite 300, South San Francisco Ca 94080.

Discussions on David Ross Parkinson

No discussions yet.